Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Bruce David Cheson's Talks
Bruce David Cheson
Lymphoma Consultant
CD30 Expression in 3L Lymphoma
May 20, 2026
Bruce David Cheson
Lymphoma Consultant
Mosunetuzumab in Untreated LBCL
May 20, 2026
Share
Mosunetuzumab in Untreated LBCL
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=11186
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Bruce David Cheson
Lymphoma Consultant
Long-Term Follow-Up of LBCL
May 8, 2026
Why are you reporting this TALK?
